BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 15566408)

  • 1. Proteoglycans and injury of the central nervous system.
    Matsui F; Oohira A
    Congenit Anom (Kyoto); 2004 Dec; 44(4):181-8. PubMed ID: 15566408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Axonal growth inhibition by chondroitin sulfate proteoglycans in the central nervous system].
    Díaz-Martínez NE; Velasco I
    Rev Invest Clin; 2009; 61(2):140-9. PubMed ID: 19637728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROCK inhibition with Y27632 activates astrocytes and increases their expression of neurite growth-inhibitory chondroitin sulfate proteoglycans.
    Chan CC; Wong AK; Liu J; Steeves JD; Tetzlaff W
    Glia; 2007 Mar; 55(4):369-84. PubMed ID: 17136770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chondroitin sulfate proteoglycan with neurite-inhibiting activity is up-regulated following peripheral nerve injury.
    Zuo J; Hernandez YJ; Muir D
    J Neurobiol; 1998 Jan; 34(1):41-54. PubMed ID: 9469617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix metalloproteinases and proteoglycans in axonal regeneration.
    Pizzi MA; Crowe MJ
    Exp Neurol; 2007 Apr; 204(2):496-511. PubMed ID: 17254568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Rho kinase pathway in chondroitin sulfate proteoglycan-mediated inhibition of neurite outgrowth in PC12 cells.
    Gopalakrishnan SM; Teusch N; Imhof C; Bakker MH; Schurdak M; Burns DJ; Warrior U
    J Neurosci Res; 2008 Aug; 86(10):2214-26. PubMed ID: 18438921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming neurite-inhibitory chondroitin sulfate proteoglycans in the astrocyte matrix.
    Cua RC; Lau LW; Keough MB; Midha R; Apte SS; Yong VW
    Glia; 2013 Jun; 61(6):972-84. PubMed ID: 23554135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration.
    Sandvig A; Berry M; Barrett LB; Butt A; Logan A
    Glia; 2004 May; 46(3):225-51. PubMed ID: 15048847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regeneration of nigrostriatal dopaminergic axons by degradation of chondroitin sulfate is accompanied by elimination of the fibrotic scar and glia limitans in the lesion site.
    Li HP; Homma A; Sango K; Kawamura K; Raisman G; Kawano H
    J Neurosci Res; 2007 Feb; 85(3):536-47. PubMed ID: 17154415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Membrane-bound CSPG mediates growth cone outgrowth and substrate specificity by Schwann cell contact with the DRG neuron cell body and not via growth cone contact.
    Castro C; Kuffler DP
    Exp Neurol; 2006 Jul; 200(1):19-25. PubMed ID: 16530184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibitory effects of chondroitin sulfate proteoglycans on oligodendrocytes.
    Siebert JR; Osterhout DJ
    J Neurochem; 2011 Oct; 119(1):176-88. PubMed ID: 21848846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chondroitin 6-sulphate synthesis is up-regulated in injured CNS, induced by injury-related cytokines and enhanced in axon-growth inhibitory glia.
    Properzi F; Carulli D; Asher RA; Muir E; Camargo LM; van Kuppevelt TH; ten Dam GB; Furukawa Y; Mikami T; Sugahara K; Toida T; Geller HM; Fawcett JW
    Eur J Neurosci; 2005 Jan; 21(2):378-90. PubMed ID: 15673437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repulsion of cerebellar granule neurons by chondroitin sulfate proteoglycans is mediated by MAPK pathway.
    Kaneko M; Kubo T; Hata K; Yamaguchi A; Yamashita T
    Neurosci Lett; 2007 Aug; 423(1):62-7. PubMed ID: 17662527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chondroitin sulfate proteoglycans in neural development and regeneration].
    Gu WL; Lu PH
    Sheng Li Ke Xue Jin Zhan; 2007 Apr; 38(2):101-5. PubMed ID: 17633220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decorin promotes robust axon growth on inhibitory CSPGs and myelin via a direct effect on neurons.
    Minor K; Tang X; Kahrilas G; Archibald SJ; Davies JE; Davies SJ
    Neurobiol Dis; 2008 Oct; 32(1):88-95. PubMed ID: 18638554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chondroitinase ABC combined with neural stem/progenitor cell transplantation enhances graft cell migration and outgrowth of growth-associated protein-43-positive fibers after rat spinal cord injury.
    Ikegami T; Nakamura M; Yamane J; Katoh H; Okada S; Iwanami A; Watanabe K; Ishii K; Kato F; Fujita H; Takahashi T; Okano HJ; Toyama Y; Okano H
    Eur J Neurosci; 2005 Dec; 22(12):3036-46. PubMed ID: 16367770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting Chondroitin Sulfate Proteoglycans: An Emerging Therapeutic Strategy to Treat CNS Injury.
    Mukherjee N; Nandi S; Garg S; Ghosh S; Ghosh S; Samat R; Ghosh S
    ACS Chem Neurosci; 2020 Feb; 11(3):231-232. PubMed ID: 31939650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of proteoglycans in Schwann cell/astrocyte interactions and in regeneration failure at PNS/CNS interfaces.
    Grimpe B; Pressman Y; Lupa MD; Horn KP; Bunge MB; Silver J
    Mol Cell Neurosci; 2005 Jan; 28(1):18-29. PubMed ID: 15607938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for cAMP in regeneration of the adult mammalian CNS.
    Spencer T; Filbin MT
    J Anat; 2004 Jan; 204(1):49-55. PubMed ID: 14690477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regeneration of lesioned entorhino-hippocampal axons in vitro by combined degradation of inhibitory proteoglycans and blockade of Nogo-66/NgR signaling.
    Mingorance A; Solé M; Munetón V; Martínez A; Nieto-Sampedro M; Soriano E; del Río JA
    FASEB J; 2006 Mar; 20(3):491-3. PubMed ID: 16407455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.